The Overlap of Bronchiectasis and Immunodeficiency with Asthma

Immunology and Allergy Clinics of North America

Volumn 33, Issue 1, 2013, Pages 61-78

  Truong, Tho ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

Asthma; Atopy; B lymphocyte; Bronchiectasis; Immunodeficiency; T lymphocyte

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

AGING; ASTHMA; ATOPY; AUTOINFLAMMATORY DISEASE; B LYMPHOCYTE; BRONCHIECTASIS; CILIARY DYSKINESIA; COMMON VARIABLE IMMUNODEFICIENCY; COMPLEMENT DEFICIENCY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; GENETIC ASSOCIATION; HEMATOLOGIC MALIGNANCY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNE DEFICIENCY; HYPER IGE SYNDROME; IMMUNE DEFICIENCY; IMMUNE STATUS; INFECTION SENSITIVITY; INNATE IMMUNITY; MUCOCILIARY CLEARANCE; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN DEPLETION; REVIEW; RISK ASSESSMENT; X LINKED AGAMMAGLOBULINEMIA;

ASTHMA; BRONCHIECTASIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES;

EID: 84872664531     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2012.10.007     Document Type: Review

References (82)

1. Barker A.F. Clinical manifestations and diagnosis of bronchiectasis in adults 2012, UpToDate.
2. Bisaccioni C., Aun M.V., Cajuela E., et al. Comorbidities in severe asthma: frequency of rhinitis, nasal polyposis, gastroesophageal reflux disease, vocal cord dysfunction and bronchiectasis. Clinics (Sao Paulo) 2009, 64(8):769-773.
3. Boyton R.J., Smith J., Ward R., et al. HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. Am J Respir Crit Care Med 2006, 173:327-333.
4. Boyton R.J., Smith J., Jones M., et al. Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity. Clin Exp Immunol 2008, 152:95-101.
5. Oguzulgen I.K., Kervan F., Ozis T., et al. The impact of bronchiectasis in clinical presentation of asthma. South Med J 2007, 100(5):468-471.
6. Haidopoulou K., Calder A., Jones A., et al. Bronchiectasis secondary to primary immunodeficiency in children: longitudinal changes in structure and function. Pediatr Pulmonol 2009, 44(7):669-675.
7. Klemola T. Deficiency of immunoglobulin A. Ann Clin Res 1987, 19:248-257.
8. Szczawinska-Poplonyk A. An overlapping syndrome of allergy and immune deficiency in children. J Allergy (Cairo) 2012, 2012:658279. [E-Review article].
9. Taylor A.E., Finney-Hayward T.K., Quint J.K., et al. Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J 2010, 35:1039-1047.
10. Tanawuttiwat T., Harindhanavudhi T. Bronchiectasis: pulmonary manifestation in chronic graft versus host disease after bone marrow transplantation. Am J Med Sci 2009, 337:292.
11. Shabestari M.S., Rezaei N. Asthma and allergic rhinitis in a patient with BTK deficiency. J Investig Allergol Clin Immunol 2008, 18(4):300-304.
12. Ogershok P.R., Hogan M.B., Welch J.E., et al. Spectrum of illness in pediatric common variable immunodeficiency. Ann Allergy Asthma Immunol 2006, 97(5):653-656.
13. Agondi R.C., Barros M.T., Rizzo L.V., et al. Allergic asthma in patients with common variable immunodeficiency. Allergy 2010, 65(4):510-515.
14. Amorosa J.K., Miller R.W., Laraya-Cuasay L., et al. Bronchiectasis in children with lymphocytic interstitial pneumonia and acquired immune deficiency syndrome. Plain film and CT observations. Pediatr Radiol 1992, 22:603-606.
15. Corominas M., Garcia J.F., Mestre M., et al. Predictors of atopy in HIV-infected patients. Ann Allergy Asthma Immunol 2000, 84(6):607-611.
16. Kearney P.J., Kershaw C.R., Stevenson P.A. Bronchiectasis in acute leukaemia. Br Med J 1977, 2:857-859.
17. Kilpatrick D.C., Chalmers J.D., MacDonald S.L., et al. Stable bronchiectasis is associated with low serum L-ficolin concentrations. Clin Respir J 2009, 3:29-33.
18. Knowles G.K., Stanhope R., Green M. Bronchiectasis complicating chronic lymphatic leukaemia with hypogammaglobulinaemia. Thorax 1980, 35:217-218.
19. Lambrecht B.N., Neyt K., GeurtsvanKessel C.H. Pulmonary defense mechanisms and inflammatory pathways in bronchiectasis. Eur Respir Mon 2011, 52:11-21.
20. Love J.T., Shearer W.T. Hypogammaglobulinemia in HIV-infected infants. N Engl J Med 1995, 333(5):321-322.
21. Okada F., Ando Y., Kondo Y., et al. Thoracic CT findings of adult T-cell leukemia or lymphoma. AJR Am J Roentgenol 2004, 182:761-767.
22. Morehead R.S. Bronchiectasis in bone marrow transplantation. Thorax 1997, 52:392-393.
23. Parkman R. Antigen-specific immunity following hematopoietic stem cell transplantation. Blood Cells Mol Dis 2008, 40:91-93.
24. Paganin F., Seneterre E., Chanez P., et al. Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med 1996, 153:110-114.
25. Patel I.S., Vlahos I., Wilkinson T.M., et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 170:400-407.
26. Pasteur M.C., Helliwell S.M., Houghton S.J., et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000, 162:1277-1284.
27. Gunn M.L., Godwin J.D., Kanne J.P., et al. High-resolution CT findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. J Thorac Imaging 2008, 23:244-250.
28. de Jong P.A., Dodd J.D., Coxson H.O., et al. Bronchiolitis obliterans following lung transplantation: early detection using computed tomographic scanning. Thorax 2006, 61:799-804.
29. Baris S., Ercan H., Cagan H.H., et al. Efficacy of intravenous immunoglobulin treatment in children with common variable immunodeficiency. J Investig Allergol Clin Immunol 2011, 21(7):514-521.
30. Berman D.M., Mafut D., Djokic B., et al. Risk factors for the development of bronchiectasis in HIV-infected children. Pediatr Pulmonol 2007, 42:871-875.
31. Sheikh S., Madiraju K., Steiner P., et al. Bronchiectasis in pediatric AIDS. Chest 1997, 112:1202-1207.
32. Buckley RH. Overview of immunodeficiency disorder. Merck manual. 2008.
33. Buckley R.H. Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 2000, 343:1313-1324.
34. Yee A., De Ravin S.S., Elliott E., et al. Severe combined immunodeficiency: a national surveillance study. Pediatr Allergy Immunol 2008, 19(4):298-302.
35. Bilton D., Jones A.L. Bronchiectasis: epidemiology and causes. Eur Respir Mon 2011, 52:1-10.
36. Brown J.S., Baxendale H., Floto R.A. Immunodeficiencies associated with bronchiectasis. Eur Respir Mon 2011, 52:178-191.
37. Shoemark A., Ozerovitch L., Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med 2007, 101:1161-1170.
38. Hilton A.M., Doyle L. Immunological abnormalities in bronchiectasis with chronic bronchial suppuration. Br J Dis Chest 1978, 72(3):207-216.
39. Lieberman-Maran L., Orzano I.M., Passero M.A., et al. Bronchiectasis in rheumatoid arthritis: report of four cases and a review of the literature-implications for management with biologic response modifiers. Semin Arthritis Rheum 2006, 35:379-387.
40. Demoruelle M.K., Weisman M.H., Simonian P.L., et al. Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity?. Arthritis Rheum 2012, 64(6):1756-1761.
41. Dhasmana D.J., Wilson R. Bronchiectasis and autoimmune disease. Eur Respir Mon 2011, 52:192-210.
42. Dogru D., Ozbas Gerceker F., Yalcin E., et al. The role of TAP1 and TAP2 gene polymorphism in idiopathic bronchiectasis in children. Pediatr Pulmonol 2007, 42:237-241.
43. Doring G., Gulbins E. Cystic fibrosis and innate immunity: how chloride channel mutations provoke lung disease. Cell Microbiol 2009, 11:208-216.
44. Cooper N., Arnold D.M. The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune disease. Br J Haematol 2010, 149:3-13.
45. Cooper N., Davies E.G., Thrasher A.J. Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin. Br J Haematol 2009, 146:120-122.
46. Busse P.J., Razvi S., Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002, 109:1001-1004.
47. Casanova J.L., Abel L. Human genetics of infectious diseases: a unified theory. EMBO J 2007, 26:915-922.
48. Eijkhout H.W., van Der Meer J.W., Kallenberg C.G., et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann Intern Med 2001, 135:165-174.
49. Eisen D.P. Mannose-binding lectin deficiency and respiratory tract infection. J Innate Immun 2010, 2:114-122.
50. Lucas M., Lee M., Lortan J., et al. Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol 2010, 125:1354-1360.
51. Aghamohammadi A., Allahverdi A., Abolhassani H., et al. Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia. Respirology 2010, 15:289-295.
52. Li A.M., Sonnappa S., Lex C., et al. Non-CF bronchiectasis: does knowing the aetiology lead to changes in management?. Eur Respir J 2005, 26:8-14.
53. Howard V., Greene J.M., Pahwa S., et al. The health status and quality of life of adults with X-linked agammaglobulinemia. Clin Immunol 2006, 118:201-208.
54. Jeurissen A., Bossuyt X., Snapper C.M. T cell-dependent and -independent responses. J Immunol 2004, 172:2728.
55. Jonsson G., Truedsson L., Sturfelt G., et al. Hereditary C2 deficiency in Sweden: frequent occurrence of invasive infection, atherosclerosis, and rheumatic disease. Medicine (Baltimore) 2005, 84:23-34.
56. Stead A., Douglas J.G., Broadfoot C.J., et al. Humoral immunity and bronchiectasis. Clin Exp Immunol 2002, 130:325-330.
57. Umetsu D.T., Ambrosino D.M., Quinti I., et al. Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. N Engl J Med 1985, 313:1247-1251.
58. Nahm M.H., Macke K., Kwon O.H., et al. Immunologic and clinical status of blood donors with subnormal levels of IgG2. J Allergy Clin Immunol 1990, 85:769-777.
59. van Kessel D.A., van Velzen-Blad H., van den Bosch J.M.M., et al. Impaired pneumococcal antibody response in bronchiectasis of unknown aetiology. Eur Respir J 2005, 25:482-489.
60. Go E.S., Ballas Z.K. Anti-pneumococcal antibody response in normal subjects: a meta-analysis. J Allergy Clin Immunol 1996, 98:205-215.
61. Gregersen S., Aalokken T.M., Mynarek G., et al. Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors. Ann Allergy Asthma Immunol 2010, 104:503-510.
62. Rodrigo M.J., Miravitlles M., Cruz M.J., et al. Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: proposal for response criteria. Clin Diagn Lab Immunol 1997, 4:168-172.
63. Lipsitch M., Whitney C.G., Zell E., et al. Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease?. PLoS Med 2005, 2:e15.
64. Litzman J., Freiberger T., Grimbacher B., et al. Mannose-binding lectin gene polymorphic variants predispose to the development of bronchopulmonary complications but have no influence on other clinical and laboratory symptoms or signs of common variable immunodeficiency. Clin Exp Immunol 2008, 153:324-330.
65. Miravitlles M., Vendrell M., de Gracia J. Antibody deficiency in bronchiectasis. Eur Respir J 2005, 26:178-180.
66. Gadola S.D., Moins-Teisserenc H.T., Trowsdale J., et al. TAP deficiency syndrome. Clin Exp Immunol 2000, 121:173-178.
67. Zimmer J., Andres E., Donato L., et al. Clinical and immunological aspects of HLA class I deficiency. QJM 2005, 98:719-727.
68. Chatila T., Wong R., Young M., et al. An immunodeficiency characterized by defective signal transduction in T lymphocytes. N Engl J Med 1989, 320:696-702.
69. Contoli M., Message S.D., Laza-Stanca V., et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006, 12:1023-1026.
70. Crothers K., Butt A.A., Gibert C.L., et al. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest 2006, 130:1326-1333.
71. Andrews T., Sullivan K.E. Infections in patients with inherited defects in phagocytic function. Clin Microbiol Rev 2003, 16:597-621.
72. Nikolaizik W.H., Warner J.O. Aetiology of chronic suppurative lung disease. Arch Dis Child 1994, 70:141-142.
73. Aujla S.J., Dubin P.J., Kolls J.K. Th17 cells and mucosal host defense. Semin Immunol 2007, 19:377-382.
74. Holland S.M., DeLeo F.R., Elloumi H.Z., et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007, 357:1608-1619.
75. Holmes A.H., Pelton S., Steinbach S., et al. HIV related bronchiectasis. Thorax 1995, 50:1227.
76. Holmes A.H., Trotman-Dickenson B., Edwards A., et al. Bronchiectasis in HIV disease. Q J Med 1992, 85:875-882.
77. Paulson M.L., Freeman A.F., Holland S.M. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3. Curr Opin Allergy Clin Immunol 2008, 8:527-533.
78. Pijnenburg M.W., Cransberg K., Wolff E., et al. Bronchiectasis in children after renal or liver transplantation: a report of five cases. Pediatr Transplant 2004, 8:71-74.
79. Zhang Z., Clarke T.B., Weiser J.N. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 2009, 119:1899-1909.
80. Bott. 2007.
81. Ochs H.D., Filipovich A.H., Veys P., et al. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant 2009, 15:84-90.
82. Moskwa P., Lorentzen D., Excoffon K.J., et al. A novel host defense system of airways is defective in cystic fibrosis. Am J Respir Crit Care Med 2007, 175:174-183.